Efficacy and Safety of D005 Vaginal Mousse on Bacterial Vaginosis

Exclusion Criteria

• •1. Hypersensitivity or allergy to the investigational devices or to chemically related products
• •2. Current use of an intrauterine device.
• •3. Current pregnancy or intention to become pregnant within 1 month after treatment
• •4. Antibiotic treatment within 2 weeks before treatment
• •5. Signs of other infections (such as chlamydia, gonorrhoea, trichomonas, candida, HSV or HPV) requiring specific antibiotic, antifungal or other treatment at screening.
• •6. Immunosuppression therapy (Allergy medications allowed) at the discretion of the PI
• •7. Existing or suspected vaginal or cervical cancer or ulcer
• •8. Unprotected vaginal sex within 24 hours prior to Visit 1
• •9. Be identified by the Investigator as inappropriate from a medical or compliance perspective to participate in this investigation (e.g. hysterectomised or inability to report daily using smartphone/computer \[eDiary\]).